Investment Summary

The BroadOak Fund and ABS Capital Partners Invest In LabConnect

On March 2, 2016, growth capital firm The BroadOak Fund and private equity firm ABS Capital Partners invested in life science company LabConnect

Investment Highlights
  • This is The BroadOak Fund’s 2nd and ABS Capital Partners’ 3rd transaction in the Life Science sector.
  • This is The BroadOak Fund’s 3rd and ABS Capital Partners’ 52nd transaction in the United States.
  • This is The BroadOak Fund’s 1st and ABS Capital Partners’ 1st transaction in Tennessee.

Investment Summary
Date 2016-03-02
Target LabConnect
Sector Life Science
Investor(s) The BroadOak Fund
ABS Capital Partners
Deal Type Growth Capital

Target

LabConnect

Johnson City, Tennessee, United States
LabConnect is a provider of global central laboratory services, including routine and esoteric laboratory testing, kit building, sample management, biorepository and scientific support services for biopharmaceutical, medical device and contract research organizations. LabConnect was founded in 2002 and is based in Johnson City, Tennessee.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 2

Investor

The BroadOak Fund

Investor Investor Investor Investor Investor

Category Growth Capital Firm
Size Small
Type Sector Focused
DESCRIPTION

The BroadOak Fund is the investment affiliate of life science focused investment bank BroadOak Capital Partners. The BroadOak Fund provides growth capital to life sciences tools and service providers that have achieved a level of commercial success. The BroadOak Fund is based in Bethesda, Maryland.

DEAL STATS #
Overall 3 of 25
Sector (Life Science) 2 of 20
Type (Growth Capital) 3 of 14
State (Tennessee) 1 of 1
Country (United States) 3 of 23
Year (2016) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-07-15 Rubicon Genomics

Ann Arbor, Michigan, United States

Rubicon Genomics, Inc. is involved in the development of amplification tools for genetic research and clinical applications.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-12-15 Rubicon Genomics

Ann Arbor, Michigan, United States

Rubicon Genomics, Inc. is involved in the development of amplification tools for genetic research and clinical applications.

Sell -
Investor

ABS Capital Partners

Hunt Valley, Maryland, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1990
PE ASSETS 2.5B USD
Size Large
Type Sector Agnostic
DESCRIPTION

ABS Capital Partners is a private equity firm that invests in later-stage growth companies in the healthcare, technology, business services, media and communications sectors. ABS provides capital to help fund growth, provide shareholder liquidity, pursue acquisitions, or to effect a management buyout. The Firm prefers US based business and will consider both majority and minority positions. ABS looks to commit $10 to $30 million per transaction. ABS Capital was formed in 1990 and has offices in Baltimore, Maryland; Waltham, Massachusetts; and San Francisco, California.

DEAL STATS #
Overall 53 of 64
Sector (Life Science) 3 of 3
Type (Growth Capital) 12 of 16
State (Tennessee) 1 of 1
Country (United States) 52 of 63
Year (2016) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-12-10 Pathology

Torrance, California, United States

Pathology, Inc. is a full-service independent women's health laboratory provides expertise in reproductive FDA donor testing as well as anatomic, molecular and digital pathology services.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-08-15 Galvanize

Denver, Colorado, United States

Galvanize LLC is a technology learning ecosystem for data scientists, software engineers, and entrepreneurs. With nine campuses across the U.S., innovative startups, aspiring students, and large enterprises all benefit from this dynamic learning community.

Buy -
Mergr

Product

Company

Legal